Variables affecting the performance of galactomannan assay in high-risk patients at a Tertiary Care Centre in India

Indian Journal of Medical Microbiology

Volumn 31, Issue 1, 2013, Pages 34-39

  Khanna, S ^a   Oberoi, J K ^a   Datta, S ^a   Aggarwal, S ^a   Wattal, C ^a  

^a SIR GANGA RAM HOSPITAL   (India)

Author keywords

Galactomannan; immunocompromised patients; invasive aspergillosis; variables

Indexed keywords

ANTIFUNGAL AGENT; PIPERACILLIN PLUS TAZOBACTAM;

ARTICLE; ASPERGILLUS; BLOOD SAMPLING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; GALACTOMANNAN ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOCOMPROMISED PATIENT; INDIA; INVASIVE ASPERGILLOSIS; MAJOR CLINICAL STUDY; NEUTROPENIA; NEUTROPHIL COUNT; PROGNOSIS; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

EID: 84881065820     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.108717     Document Type: Article

References (20)

1. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998;26:781-803.
2. Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005;18:44-69.
3. Paterson DL, Singh N. Invasive aspergillosis in transplant recipients. Medicine (Baltimore) 1999;78:123-38.
4. Herbrecht R, Moghaddam A, Mahmal I, Natarajaname S, Fornecker LM, Letscherbru V. Invasive aspergillosis in the hematologic and immunologic patient: New fi ndings and key questions in leukemia. Med Mycol 2005;43:S239-242.
5. Fukuda T, Boeckh M, Carter RA, Sandmaier BM, Maris MB, Maloney DG, et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 2003;102:827-33.
6. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev1999;12:310-50.
7. Klont RR, Mennink-Kersten MASH, Verweij PE. Utility of Aspergillus antigen detection in specimens other than serum specimens. Clin Infect Dis 2004;39:1467-74.
8. Verweij PE, Stynen D, Rijs AJ, de Pauw BE, Hoogkamp-Korstanje JA, Meis JF, et al. Sandwich enzymelinked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients. J Clin Microbiol 1995;33:1912-4.
9. Morelle W, Bernard M, Debeaupuis JP, Buitrago M, Tabouret M, Latge JP. Galactomannoproteins of Aspergillus fumigatus. Eukaryot Cell 2005;41:308-16.
10. Pauw BD, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised Defi nitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-21.
11. Larone DH. Medically important fungi: A guide to identifi cation. 3rd edition. Washington DC: American Society for Microbiology; 2005.
12. Maertens J, Van Eldere J, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 2002;186:1297-306.
13. Fortun J, Martin-Davila P, Alvarez ME, Sanchez-Sousa A, Quereda C, Navas E, et al. Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients. Transplantation 2001;71:145-9.
14. Herbrecht R, Letscher-Bru V, Oprea C, Lioure B, Waller J, Campos F, et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002;20:1898-906.
15. Mori AY, Kanda Y, Oshima K, Kako S, Shinohara A, Nakasone H, et al. False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation. J Antimicrob Chemother 2008;61:411-6.
16. Adam O, Auperin A, Wilquin F, Bourhis JH, Gachot J, Chachaty E. Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin Infect Dis 2004;38:917-20.
17. Fortun J, Martin-Davila P, Alvarez ME, Norman F, Sanchez-Sousa A, Gajate L, et al. False positive results of Aspergillus galactomannan antigenemia in liver transplant recipients. Transplantation 2009;87:256-60.
18. Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: Variables that affect performance. J Infect Dis 2004;190:641-9.
19. Cordonnier C, Botterel F, Ben Amor R, Pautas C, Maury S, Kuentz M, et al. Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis. Clin Microbiol Infect 2009;15:81-6.
20. Boutboul F, Alberti C, Leblanc T, Sulahian A, Gluckman E, Derouin F, et al. Invasive aspergillosis in allogenic stem cell transplant recipients: Increasing antigenemia is associated with progressive disease. Clin Infect Dis 2002;34:939-43.